Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 1,292,014 | 1,326,711 | 1,309,934 | 1,208,647 | 1,203,342 |
| Cost of Goods | 133,197 | 139,637 | 123,527 | 100,503 | 103,113 |
| Gross Profit | 1,158,817 | 1,187,074 | 1,186,407 | 1,108,144 | 1,100,229 |
| Operating Expenses | 789,644 | 778,609 | 698,441 | 697,834 | 684,059 |
| Operating Income | 369,370 | 409,102 | 488,493 | 410,813 | 416,283 |
| Other Income | 15,144 | -3,973 | -7,727 | -11,728 | 9,951 |
| Pre-tax Income | 384,514 | 405,129 | 480,766 | 399,085 | 426,234 |
| Income Tax | 82,148 | 104,920 | 127,104 | 95,036 | 117,468 |
| Net Income Continuous | 302,366 | 300,209 | 353,662 | 304,049 | 308,766 |
| Minority Interests | -295 | -28 | 1,836 | 16,015 | 14,435 |
| Net Income | $302,661 | $300,237 | $351,826 | $288,034 | $294,331 |
| EPS Basic Total Ops | 1.26 | 1.23 | 1.45 | 1.19 | 1.22 |
| EPS Basic Continuous Ops | 1.26 | 1.24 | 1.46 | 1.25 | 1.28 |
| EPS Diluted Total Ops | 1.25 | 1.23 | 1.43 | 1.18 | 1.20 |
| EPS Diluted Continuous Ops | 1.25 | 1.22 | 1.44 | 1.24 | 1.26 |
| EBITDA(a) | $453,315 | $497,823 | $575,860 | $501,113 | $508,828 |